The use of cardiac troponins (T or I) measurement in cardiology and various clinical setting;Dosage des isoformes cardiaques des troponines T ou I : intérêt en cardiologie et en anesthésie-réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 10, 2006, Pages 1053-1063

  Berroeta C ^a   Provenchere S ^a   Mongredien, A ^a   Lasocki, S ^a   Benessiano, J ^a   Dehoux, M ^a   Philip, I ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Acute coronary syndrome; Cardiac troponin; Diagnosis; Myocardial infarction; Perioperative infarction; Prognosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARDIAC AGENT; CREATINE KINASE MB; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOLOGY; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HEART CONTUSION; HEART INFARCTION; HEART INJURY; HEART MUSCLE; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HEART VALVE SURGERY; HUMAN; INVASIVE PROCEDURE; LUNG EMBOLISM; MYOCARDITIS; PERCUTANEOUS CORONARY INTERVENTION; PERICARDITIS; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

ANESTHESIA RECOVERY PERIOD; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; DECISION TREES; HUMANS; MYOCARDIAL INFARCTION; TROPONIN I; TROPONIN T;

EID: 33750359389     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2005.05.017     Document Type: Short Survey

References (135)

1. Larue C., Defacque-Lacquement H., Calzolari C., Le Nguyen D., and Pau B. New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides. Mol. Immunol. 29 (1992) 271-278
2. Giuliani I., Bertinchant J.P., Granier C., Laprade M., Chocron S., Toubin G., et al. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Clin. Chem. 45 (1999) 213-222
3. Lefevre G. Les troponines: aspects biologicaques et cliniques. Ann. Biol. Clin. (Paris) 58 (2000) 39-48
4. Katrukha A.G., Bereznikova A.V., Esakova T.V., Pettersson K., Lovgren T., Severina M.E., et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin. Chem. 43 (1997) 1379-1385
5. Wu A.H., Feng Y.J., Moore R., Apple F.S., McPherson P.H., Buechler K.F., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin. Chem. 44 (1998) 1198-1208
6. McDonough J.L., Arrell D.K., and Van Eyk J.E. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ. Res. 84 (1999) 9-20
7. Lavoinne A., and Cauliez B. Les troponines I et T cardiaques : des marqueurs spécifiques du cardiomyocyte. Rev. Med. Interne 25 (2004) 115-123
8. Jaffe A.S., Landt Y., Parvin C.A., Abendschein D.R., Geltman E.M., and Ladenson J.H. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin. Chem. 42 (1996) 1770-1776
9. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 144 (2002) 981-986
10. Jaffe A.S., Ravkilde J., Roberts R., Naslund U., Apple F.S., Galvani M., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
11. Labugger R., Organ L., Collier C., Atar D., and Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102 (2000) 1221-1226
12. Jaffe A. Caveat emptor. Am. J. Med. 115 (2003) 241-244
13. Conzen P.F., Fischer S., Detter C., and Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 99 (2003) 826-833
14. Adams III J.E., Bodor G.S., Davila-Roman V.G., Delmez J.A., Apple F.S., Ladenson J.H., et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993) 101-106
15. Apple F.S. The specificity of biochemical markers of cardiac damage: a problem solved. Clin. Chem. Lab. Med. 37 (1999) 1085-1089
16. Bohner J., von Pape K.W., Hannes W., and Stegmann T. False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies. Clin. Chem. 42 (1996) 2046
17. Venge P., Lindahl B., and Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin. Chem. 47 (2001) 959-961
18. Hamm C.W., Giannitsis E., and Katus H.A. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 106 (2002) 2871-2872
19. Cannon C.P., Battler A., Brindis R.G., Cox J.L., Ellis S.G., Every N.R., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J. Am. Coll. Cardiol. 38 (2001) 2114-2130
20. Braunwald E., Califf R.M., Cannon C.P., Fox K.A., Fuster V., Gibler W.B., et al. Redefining medical treatment in the management of unstable angina. Am. J. Med. 108 (2000) 41-53
21. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 102 (2000) 1193-1209
22. Lindahl B. Markers of myocardial damage in acute coronary syndromes--therapeutic implications. Clin. Chim. Acta 311 (2001) 27-32
23. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
24. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36 (2000) 959-969
25. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., and Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin. Chem. 49 (2003) 1331-1336
26. Galvani M., Ottani F., Ferrini D., Ladenson J.H., Destro A., Baccos D., et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 95 (1997) 2053-2059
27. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., and Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J. Am. Coll. Cardiol. 38 (2001) 478-485
28. Morrow D.A., Cannon C.P., Rifai N., Frey M.J., Vicari R., Lakkis N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286 (2001) 2405-2412
29. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N. Engl. J. Med. 335 (1996) 1333-1341
30. Lindahl B., Diderholm E., Lagerqvist B., Venge P., and Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J. Am. Coll. Cardiol. 38 (2001) 979-986
31. Bertrand M.E., Simoons M.L., Fox K.A., Wallentin L.C., Hamm C.W., McFadden E., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 23 (2002) 1809-1840
32. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., and Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N. Engl. J. Med. 337 (1997) 1648-1653
33. Kontos M.C., Anderson F.P., Alimard R., Ornato J.P., Tatum J.L., and Jesse R.L. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. J. Am. Coll. Cardiol. 36 (2000) 1818-1823
34. Polanczyk C.A., Lee T.H., Cook E.F., Walls R., Wybenga D., Printy-Klein G., et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J. Am. Coll. Cardiol. 32 (1998) 8-14
35. Sayre M.R., Kaufmann K.H., Chen I.W., Sperling M., Sidman R.D., Diercks D.B., et al. Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. Ann. Emerg. Med. 31 (1998) 539-549
36. Uettwiller-Geiger D., Wu A.H., Apple F.S., Jevans A.W., Venge P., Olson M.D., et al. Multicenter evaluation of an automated assay for troponin I. Clin. Chem. 48 (2002) 869-876
37. Apple F.S., Anderson F.P., Collinson P., Jesse R.L., Kontos M.C., Levitt M.A., et al. Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. Clin. Chem. 46 (2000) 1604-1609
38. Hamm C.W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C.M., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N. Engl. J. Med. 340 (1999) 1623-1629
39. Luscher M.S., Thygesen K., Ravkilde J., and Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation 96 (1997) 2578-2585
40. Cannon C.P., McCabe C.H., Wilcox R.G., Langer A., Caspi A., Berink P., et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102 (2000) 149-156
41. Morrow D.A., Antman E.M., Tanasijevic M., Rifai N., de Lemos J.A., McCabe C.H., et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J. Am. Coll. Cardiol. 36 (2000) 1812-1817
42. Heeschen C., Hamm C.W., Goldmann B., Deu A., Langenbrink L., and White H.D. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 354 (1999) 1757-1762
43. Lindahl B., Venge P., and Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 93 (1996) 1651-1657
44. Lindahl B., Venge P., and Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J. Am. Coll. Cardiol. 29 (1997) 43-48
45. Budaj A., Brieger D., Steg P.G., Goodman S.G., Dabbous O.H., Fox K.A., et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am. Heart J. 146 (2003) 999-1006
46. Frostfeldt G., Gustafsson G., Lindahl B., Nygren A., Venge P., and Wallentin L. Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction. Coron. Artery Dis. 12 (2001) 227-237
47. Wu A.H., and Ford L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?. Clin. Chim. Acta 284 (1999) 161-174
48. Abdelmeguid A.E., and Topol E.J. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation 94 (1996) 3369-3375
49. Simoons M.L., van den Brand M., Lincoff M., Harrington R., van der Wieken R., Vahanian A., et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur. Heart J. 20 (1999) 1112-1119
50. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
51. Adams III J.E., Sicard G.A., Allen B.T., Bridwell K.H., Lenke L.G., Davila-Roman V.G., et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N. Engl. J. Med. 330 (1994) 670-674
52. Haggart P.C., Adam D.J., Ludman P.F., and Bradbury A.W. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery. Br. J. Surg. 88 (2001) 1196-1200
53. Jules-Elysee K., Urban M.K., Urquhart B., and Milman S. Troponin I as a diagnostic marker of a perioperative myocardial infarction in the orthopedic population. J. Clin. Anesth. 13 (2001) 556-560
54. Lopez-Jimenez F., Goldman L., Sacks D.B., Thomas E.J., Johnson P.A., Cook E.F., et al. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J. Am. Coll. Cardiol. 29 (1997) 1241-1245
55. Filipovic M., Jeger R., Probst C., Girard T., Pfisterer M., Gurke L., et al. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. J. Am. Coll. Cardiol. 42 (2003) 1767-1776
56. Kim L.J., Martinez E.A., Faraday N., Dorman T., Fleisher L.A., Perler B.A., et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 106 (2002) 2366-2371
57. Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J. Am. Coll. Cardiol. 42 (2003) 1547-1554
58. Jaffe A.S. A small step for man, a leap forward for postoperative management. J. Am. Coll. Cardiol. 42 (2003) 1555-1557
59. Birdi I., Angelini G.D., and Bryan A.J. Biochemical markers of myocardial injury during cardiac operations. Ann. Thorac. Surg. 63 (1997) 879-884
60. Alyanakian M.A., Dehoux M., Chatel D., Seguret C., Desmonts J.M., Durand G., et al. Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 12 (1998) 288-294
61. Dehoux M., Provenchere S., Benessiano J., Lasocki S., Lecharny J.B., Bronchard R., et al. Utility of cardiac troponin measurement after cardiac surgery. Clin. Chim. Acta 311 (2001) 41-44
62. Jain U., Laflamme C.J., Aggarwal A., Ramsay J.G., Comunale M.E., Ghoshal S., et al. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 86 (1997) 576-591
63. Burns R.J., Gladstone P.J., Tremblay P.C., Feindel C.M., Salter D.R., Lipton I.H., et al. Myocardial infarction determined by technetium-99m pyrophosphate single-photon tomography complicating elective coronary artery bypass grafting for angina pectoris. Am. J. Cardiol. 63 (1989) 1429-1434
64. Landesberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J. Cardiothorac. Vasc. Anesth. 17 (2003) 90-100
65. Svedjeholm R., Dahlin L.G., Lundberg C., Szabo Z., Kagedal B., Nylander E., et al. Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery?. Eur. J. Cardiothorac. Surg. 13 (1998) 655-661
66. Carrier M., Pellerin M., Perrault L.P., Solymoss B.C., and Pelletier L.C. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann. Thorac. Surg. 69 (2000) 435-440
67. Benoit M.O., Paris M., Silleran J., Fiemeyer A., and Moatti N. Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit. Care Med. 29 (2001) 1880-1886
68. Greenson N., Macoviak J., Krishnaswamy P., Morrisey R., James C., Clopton P., et al. Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am. Heart J. 141 (2001) 447-455
69. Lasocki S., Provenchere S., Benessiano J., Vicaut E., Lecharny J.B., Desmonts J.M., et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology 97 (2002) 405-411
70. Mongredien A., Provenchere S., Berroeta C., Verpillat P., Desmonts J.M., Durand G., et al. Prognostic value of postoperative cTnI in cardiac surgery: comparison of Abbott and Dade assays. Clin. Chim. Acta 354 (2005) 209-211
71. Brener S.J., Lytle B.W., Schneider J.P., Ellis S.G., and Topol E.J. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J. Am. Coll. Cardiol. 40 (2002) 1961-1967
72. Costa M.A., Carere R.G., Lichtenstein S.V., Foley D.P., de Valk V., Lindenboom W., et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 104 (2001) 2689-2693
73. Fremes S.E., Tamariz M.G., Abramov D., Christakis G.T., Sever J.Y., Sykora K., et al. Late results of the Warm Heart Trial: the influence of nonfatal cardiac events on late survival. Circulation 102 (2000) III339-III345
74. Klatte K., Chaitman B.R., Theroux P., Gavard J.A., Stocke K., Boyce S., et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J. Am. Coll. Cardiol. 38 (2001) 1070-1077
75. Marso S.P., Bliven B.D., House J.A., Muehlebach G.F., and Borkon A.M. Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur. Heart J. 24 (2003) 1323-1328
76. Fellahi J.L., Gue X., Richomme X., Monier E., Guillou L., and Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 99 (2003) 270-274
77. Coma-Canella I., Gamallo C., Martinez Onsurbe P., and Lopez-Sendon J. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur. Heart J. 9 (1988) 534-540
78. Konstantinides S., Geibel A., Olschewski M., Kasper W., Hruska N., Jackle S., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 (2002) 1263-1268
79. Mehta N.J., Jani K., and Khan I.A. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am. Heart J. 145 (2003) 821-825
80. Muller-Bardorff M., Weidtmann B., Giannitsis E., Kurowski V., and Katus H.A. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin. Chem. 48 (2002) 673-675
81. Giannitsis E., Muller-Bardorff M., Kurowski V., Weidtmann B., Wiegand U., Kampmann M., et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102 (2000) 211-217
82. Goldhaber S.Z. Cardiac biomarkers in pulmonary embolism. Chest 123 (2003) 1782-1784
83. Goldhaber S.Z., and Elliott C.G. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation 108 (2003) 2834-2838
84. Tapson V.F. Diagnosing and managing acute pulmonary embolism: role of cardiac troponins. Am. Heart J. 145 (2003) 751-753
85. Angelini A., Calzolari V., Calabrese F., Boffa G.M., Maddalena F., Chioin R., et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84 (2000) 245-250
86. Smith S.C., Ladenson J.H., Mason J.W., and Jaffe A.S. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95 (1997) 163-168
87. Ammann P., Naegeli B., Schuiki E., Straumann E., Frielingsdorf J., Rickli H., et al. Long-term outcome of acute myocarditis is independent of cardiac enzyme release. Int. J. Cardiol. 89 (2003) 217-222
88. Lauer B., Niederau C., Kuhl U., Schannwell M., Pauschinger M., Strauer B.E., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J. Am. Coll. Cardiol. 30 (1997) 1354-1359
89. Bonnefoy E., Godon P., Kirkorian G., Fatemi M., Chevalier P., and Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur. Heart J. 21 (2000) 832-836
90. Imazio M., Demichelis B., Cecchi E., Belli R., Ghisio A., Bobbio M., et al. Cardiac troponin I in acute pericarditis. J. Am. Coll. Cardiol. 42 (2003) 2144-2148
91. Sarda L., Colin P., Boccara F., Daou D., Lebtahi R., Faraggi M., et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J. Am. Coll. Cardiol. 37 (2001) 786-792
92. Ammann P., Fehr T., Minder E.I., Gunter C., and Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 27 (2001) 965-969
93. Spies C., Haude V., Fitzner R., Schroder K., Overbeck M., Runkel N., et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113 (1998) 1055-1063
94. Turner A., Tsamitros M., and Bellomo R. Myocardial cell injury in septic shock. Crit. Care Med. 27 (1999) 1775-1780
95. Ver Elst K.M., Spapen H.D., Nguyen D.N., Garbar C., Huyghens L.P., and Gorus F.K. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin. Chem. 46 (2000) 650-657
96. Tavernier B., Li J.M., El-Omar M.M., Lanone S., Yang Z.K., Trayer I.P., et al. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J. 15 (2001) 294-296
97. Ammann P., Maggiorini M., Bertel O., Haenseler E., Joller-Jemelka H.I., Oechslin E., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J. Am. Coll. Cardiol. 41 (2003) 2004-2009
98. Guest T.M., Ramanathan A.V., Tuteur P.G., Schechtman K.B., Ladenson J.H., and Jaffe A.S. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 273 (1995) 1945-1949
99. Relos R.P., Hasinoff I.K., and Beilman G.J. Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit. Care Med. 31 (2003) 2598-2603
100. Karpati P.C., Rossignol M., Pirot M., Cholley B., Vicaut E., Henry P., et al. High Incidence of Myocardial Ischemia during Postpartum Hemorrhage. Anesthesiology 100 (2004) 30-36
101. James P., Ellis C.J., Whitlock R.M., McNeil A.R., Henley J., and Anderson N.E. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 320 (2000) 1502-1504
102. Dixit S., Castle M., Velu R.P., Swisher L., Hodge C., and Jaffe A.S. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch. Intern. Med. 160 (2000) 3153-3158
103. Tung P., Kopelnik A., Banki N., Ong K., Ko N., Lawton M.T., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 35 (2004) 548-551
104. Deibert E., Aiyagari V., and Diringer M.N. Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation. Heart 84 (2000) 205-207
105. James S., Armstrong P., Califf R., Simoons M.L., Venge P., Wallentin L., et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am. J. Med. 115 (2003) 178-184
106. Etgen T., Baum H., Sander K., and Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 36 (2005) 270-275
107. Riou B., Dreux S., Roche S., Arthaud M., Goarin J.P., Leger P., et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 92 (1995) 409-414
108. Grant J.W., Canter C.E., Spray T.L., Landt Y., Saffitz J.E., Ladenson J.H., et al. Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients. Circulation 90 (1994) 2618-2621
109. Boudaa C., Perrier J.F., Lalot J.M., Treuvey L., Voltz C., Strub P., et al. Analyse des critères qui participent à la décision de prélèvement cardiaque chez les patients en état de mort encéphalique. Ann. Fr. Anesth. Reanim. 22 (2003) 765-772
110. Mullen J.C., Bentley M.J., Scherr K.D., Chorney S.G., Burton N.I., Tymchak W.J., et al. Troponin T and I are not reliable markers of cardiac transplant rejection. Eur. J. Cardiothorac. Surg. 22 (2002) 233-237
111. Wang C.W., Steinhubl S.R., Castellani W.J., Van Lente F., Miller D.P., James K.B., et al. Inability of serum myocyte death markers to predict acute cardiac allograft rejection. Transplantation 62 (1996) 1938-1941
112. Dengler T.J., Zimmermann R., Braun K., Muller-Bardorff M., Zehelein J., Sack F.U., et al. Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J. Am. Coll. Cardiol. 32 (1998) 405-412
113. Chance J.J., Segal J.B., Wallerson G., Kasper E., Hruban R.H., Kickler T.S., et al. Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection. Clin. Chim. Acta 312 (2001) 31-39
114. Vijay P., Scavo V.A., Morelock R.J., Sharp T.G., and Brown J.W. Donor cardiac troponin T: a marker to predict heart transplant rejection. Ann. Thorac. Surg. 66 (1998) 1934-1939
115. Labarrere C.A., Nelson D.R., Cox C.J., Pitts D., Kirlin P., and Halbrook H. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA 284 (2000) 457-464
116. Ferjani M., Droc G., Dreux S., Arthaud M., Goarin J.P., Riou B., et al. Circulating cardiac troponin T in myocardial contusion. Chest 111 (1997) 427-433
117. Okubo N., Hombrouck C., Fornes P., Cosson C., Samii K., Mazoit J.X., et al. Cardiac troponin I and myocardial contusion in the rabbit. Anesthesiology 93 (2000) 811-817
118. Salim A., Velmahos G.C., Jindal A., Chan L., Vassiliu P., Belzberg H., et al. Clinically significant blunt cardiac trauma: role of serum troponin levels combined with electrocardiographic findings. J. Trauma 50 (2001) 237-243
119. Bertinchant J.P., Polge A., Mohty D., Nguyen-Ngoc-Lam R., Estorc J., Cohendy R., et al. Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspected myocardial contusion after blunt chest trauma. J. Trauma 48 (2000) 924-931
120. Fulda G.J., Giberson F., Hailstone D., Law A., and Stillabower M. An evaluation of serum troponin T and signal-averaged electrocardiography in predicting electrocardiographic abnormalities after blunt chest trauma. J. Trauma 43 (1997) 304-310 (discussion 10-2)
121. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
122. Potluri S., Ventura H.O., Mulumudi M., and Mehra M.R. Cardiac troponin levels in heart failure. Cardiol. Rev. 12 (2004) 21-25
123. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
124. Missov E., Calzolari C., and Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96 (1997) 2953-2958
125. Solaro R.J. Troponin I, stunning, hypertrophy, and failure of the heart. Circ. Res. 84 (1999) 122-124
126. Solaro R.J., and Rarick H.M. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ. Res. 83 (1998) 471-480
127. Sorsa T., Pollesello P., Permi P., Drakenberg T., and Kilpelainen I. Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. J. Mol. Cell. Cardiol. 35 (2003) 1055-1061
128. Foster D.B., and Van Eyk J.E. In search of the proteins that cause myocardial stunning. Circ. Res. 85 (1999) 470-472
129. Diesel W., Emms M., Knight B.K., Noakes T.D., Swanepoel C.R., van Zyl Smit R., et al. Morphologic features of the myopathy associated with chronic renal failure. Am. J. Kidney Dis. 22 (1993) 677-684
130. Haller C., Zehelein J., Remppis A., Muller-Bardorff M., and Katus H.A. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin. Chem. 44 (1998) 930-938
131. Fredericks S., Murray J.F., Bewick M., Chang R., Collinson P.O., Carter N.D., et al. Cardiac troponin T and creatine kinase MB are not increased in exterior oblique muscle of patients with renal failure. Clin. Chem. 47 (2001) 1023-1030
132. Dierkes J., Domrose U., Westphal S., Ambrosch A., Bosselmann H.P., Neumann K.H., et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102 (2000) 1964-1969
133. Fehr T., Knoflach A., Ammann P., Pei P., and Binswanger U. Differential use of cardiac troponin T vs I in hemodialysis patients. Clin. Nephrol. 59 (2003) 35-39
134. Aviles R.J., Askari A.T., Lindahl B., Wallentin L., Jia G., Ohman E.M., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N. Engl. J. Med. 346 (2002) 2047-2052
135. Bertinchant J.P. Troponines et insuffisance rénale chronique chez l'hémodialysé. Arch. Mal. Coeur Vaiss. 97 (2004) 157-164